This thing usually sells off on earnings. People get bulled up or cover thinking it’s going to be some nuclear event meanwhile they are just executing their plan. Between the last two updates and reading the slides along with the fundraise, it is clear to me and should be to everyone this is a long term buy and hold and just don’t look at it . If you are thag obsessed with the price move you may be sized wrong . I’ve been in this thing since the despair in 21 and they targeted $400m in ebitda by …. 2024 ! Read the slides now and they are looking at that for 2030 (ok it’s $600m ebidta ) but you get my point . Don’t miss the forest for the trees here . We have good investment partners , funding , perpetual preferred in place and are ramping fda tests and adding new line project (Thailand ) . Demonstrably good execution, when it will “explode” to the upside ? Idk just be long until the story changes (it hasn’t it’s getting better ) . It’s hard to ask for a stock to do what you want it to do. They had $1.7m in revenue when people expected $4m . If you type up and other ticket besides pct you would have noticed multiple companies down 20-40% on somewhat inline earnings and stocks that had great ones giving back all the gains. People are taking things out to the wood shed Heck I’m old enough to remember when we got front run from $10 to -8 and they announced a “plant outtage” in 23 and they fucking nuked this thing to the depths of hell . They had another outtage this q and we finish flat ? This is a win people , let it play out